Market: 99% of patients are not treated effectively today

Of the 1 million patients diagnosed with articular cartilage defects each year, less than 1% are treated with effective therapies. Techvest, LLC estimates the annual market potential for a treatment superior to current therapies at US$ 1 billion in the US alone.

In contrast, Millennium Research Group reported a current market size of 55 US$ million world wide. The main factor currently limiting market development Millennium Research Group identified as the requirement for two surgeries. Clearly, a biological solution that requires only a single surgical procedure and that is cost effective, should have a enormous impact in the cartilage repair market. CellCoTec believes that its approach will have that impact.